Epstein-Barr virus infection and cholestatic hepatitis;Infección por el virus de Epstein-Barr y hepatitis aguda colestásica

Anales de Medicina Interna

Volumn 23, Issue 10, 2006, Pages

  Barreales Valbuena, Mónica ^a,b   Perez Carreras M ^a   Meizoso, T ^a   Garrido, M ^a   Masedo, A ^a   Colina, F ^a   Solis J A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b NONE   (Spain)

Author keywords

Cholestasis; Epstein Barr virus; Infectious mononucleosis; Toxic hepatitis; Viral hepatitis

Indexed keywords

AMINOTRANSFERASE; HETEROPHILE ANTIBODY; IBUPROFEN; IMMUNOGLOBULIN M ANTIBODY; PARACETAMOL; VALERIAN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTHRALGIA; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; COUGHING; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEVER; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIVER BIOPSY; LYMPHADENOPATHY; MALE; MIGRAINE; SEROLOGY; SPLENOMEGALY; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 34250720996     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Méndez-Sánchez N, Uribe M. Infectious mononucleosis hepatitis: a case-report. Ann Hepatol 2004; 3: 75-76.
2. Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994; 14: 1-13.
3. Kimura H, Nagasaka T, Hoshino Y, Hayashi N, Tanaka N, Xu JL, et al. Severe hepatitis caused by Epstein.Barr virus without infection of hepatocytes. Hum Pathol 2001; 32: 757-762.
4. Hinedi TB, Koff RS. Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult. Dig Dis Sci 2003; 48: 539-541.
5. Edoute Y, Baruch Y, Lachter J, Furman E, Bassan L, Assy N. Severe cholestatis jaundice induced by Epstein-Barr virus infection in the elderly. J Gastroenterol Hepatol 1998; 13. 821-824.
6. Bernstein CN, Minuk GY. Infectious mononucleosis presenting with cholestatic liver disease. Ann Intern Med 1998; 128: 509.
7. Papatheodoridis GV, Delladetsima JK, Kavallierierou L, Kapranos N, Tassopoulos NC. Fulminant hepatitis due to Epstein-Barr virus infection. J Hepatol 1995; 23: 348-350.
8. Purtillo DT, Sakamoto K. Epstein-Barr virus and human disease: immune response determines the clinical and pathologic expresion. Hum Pathol 1981; 12:677-679.
9. Nenert M., Mavier P., Dubuc N, Deforges L, Zafrani ES. Epstein-Barr virus infection and hepatic fibrining granulomas. Hum Pathol 1988; 19:608-610.
10. Sevilla J, Escudero MC, Jiménez R, González-Vicent M, Manzanares J, García-Novo D, et al. Severe systemic autoimmune disease associated with Epstein-Barr virus infection. J Pediatr Hematol Oncol 2004; 26:831-833.
11. Andrade RJ, Lucena MI. Toxicidad por medicamentos: detección y tratamiento. Gastroenterol Hepatol 2005; 28: 1-11.
12. O'Connor N, Dargan PI, Jones AL. Hepatocellular damage from non-steroidal anti-inflammatory drugs. QJM 2003; 96: 787-791.
13. Rodríguez-González FJ, Montero JL, Puente J, Fraga E, Costan G, Barrera P et al. Orthotopic liver transplantation after subacute liver failure induced by therapeutic doses of ibuprofen. Am J Gastroenterol 2002; 97: 2476-2477.
14. Chitturi S, Farrell GC. Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000; 15: 1093-1099.
15. Park E, Esrason KT, Wu VH. Hepatotoxicity of herbal remedies: an emerging dilema. Prog Transplant 2004; 14: 91-96.
16. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002; 22: 195-206.
17. Vo LT, Chan D, King RG. Investigation of the effects of peppermint oil and valerian on rat liver and cultured human liver cells. Clin Exp Pharmacol Physiol 2003; 30: 799-804.
18. Chan TY, Tang CH, Critchley JA. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian). Postgrad Med J 1995; 71: 227-228.
19. Levy M. Role of viral infections in the induction of adverse drug reactions. Drug Saf 1997; 16: 1-8.
20. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003; 148: 1032-1034.
21. Riley TR, Smith JP. Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series. Am J Gastroenterol 1998; 93: 1563-1565.
22. Mizuno F, Koizumi S, Osato T, Kokwaro JO, Ito Y. Chinese and african euphorbiaceae plant extracts: markedly enhancing effect on Epstein-Barr virus-induced transformation. Cancer Lett 1983; 19: 199-205.
23. Hildesheim A, West S, De Veyra E, De Guzmán MF, Jurado A, Jones C et al. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma. Cancer Res 1992; 52: 3048-3051.
24. Abebe W. Herbal medication: potencial for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002; 27: 391-401.
25. Yuge A, Kinoshita E, Moriuchi M, Ohno Y, Haga H, Moriuchi H. Persistent hepatitis associated with chronic active Epstein-Barr virus infection. Pediatr Infect Dis J 2004; 23:74-76.